This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sato, Y. Articles by Oizumi, K. Search for Related Content PubMed PubMed Citation Articles by Sato, Y. Articles by Oizumi, K.

(Stroke. 1997;28:736-739.)
© 1997 American Heart Association, Inc.

Articles

Amelioration of Hemiplegia-Associated Osteopenia More Than 4 Years After Stroke by 1-Hydroxyvitamin D₃ and Calcium Supplementation

Yoshihiro Sato, MD; Hiroshi Maruoka, MD Kotaro Oizumi, MD

From the Department of Neurology, Futase Social Insurance Hospital, Iizuka (Y.S., H.M.), and the First Department of Internal Medicine, Kurume University School of Medicine, Kurume (K.O.), Japan.

Correspondence to Yoshihiro Sato, MD, Department of Neurology, Futase Social Insurance Hospital, 1243 Ikawa, Iizuka 820, Japan. E-mail y-sato{at}kurume.ktarn.or.jp

Background and Purpose It has been demonstrated that bone mass was significantly reduced on the hemiplegic side of stroke patients, which might increase their risk of hip fracture. We evaluated the efficacy of 1-hydroxyvitamin D₃ [1(OH)D₃] and supplemental elemental calcium in maintaining bone mass and decreasing the incidence of hip fractures after hemiplegic stroke.

Methods In a randomized study, 64 patients with hemiplegia after stroke with a mean duration of illness of 4.8 years received either 1 µg 1(OH)D₃ daily (treatment group, n=30) or an inactive placebo (placebo group, n=34) for 6 months and were observed for this duration. Both groups received 300 mg of elemental calcium daily. The bone mineral density (BMD) and metacarpal index (MCI) in the second metacarpals were determined by computed x-ray densitometry. The incidence of hip fractures in these patients was recorded.

Results BMD on the hemiplegic side decreased by 2.4% in the treatment group and 8.9% in the placebo group (P=.0021), while BMD on the intact side increased by 3.5% and decreased by 6.3% in the treated and placebo groups, respectively (P=.0177). In the treatment group, the difference in BMD between hemiplegic and nonhemiplegic sides decreased significantly compared with that before randomization. This difference increased in the placebo group. We observed a similar improvement in MCI in the treatment group but not in the placebo group. Four patients in the placebo group suffered a hip fracture compared with none in the treatment group (P=.0362).

Conclusions Treatment with 1(OH)D₃ and supplemental elemental calcium can reduce the risk of hip fractures and can prevent further decreases in BMD and MCI on the hemiplegic side of patients with a long-standing stroke. Treatment also may improve these indices on the intact side.

Key Words: calcium • complications • hemiplegia • osteoporosis • vitamin D

This article has been cited by other articles:

				S. Pilz, H. Dobnig, J. E. Fischer, B. Wellnitz, U. Seelhorst, B. O. Boehm, and W. Marz Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography Stroke, September 1, 2008; 39(9): 2611 - 2613. [Abstract] [Full Text] [PDF]

				J. Marsden, L. M. Gibson, C. E. Lightbody, A. K. Sharma, M. Siddiqi, and C. Watkins Can early onset bone loss be effectively managed in post-stroke patients? An integrative review of the evidence Age Ageing, March 1, 2008; 37(2): 142 - 150. [Abstract] [Full Text] [PDF]

				P. C. Gotzsche, A. Hrobjartsson, K. Maric, and B. Tendal Data Extraction Errors in Meta-analyses That Use Standardized Mean Differences JAMA, July 25, 2007; 298(4): 430 - 437. [Abstract] [Full Text] [PDF]

				Y. Sato, J. Iwamoto, T. Kanoko, and K. Satoh Risedronate therapy for prevention of hip fracture after stroke in elderly women Neurology, March 8, 2005; 64(5): 811 - 816. [Abstract] [Full Text] [PDF]

				Y. Sato, N. Metoki, J. Iwamoto, and K. Satoh Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients Neurology, August 12, 2003; 61(3): 338 - 342. [Abstract] [Full Text] [PDF]

				K. E.S. Poole, J. Reeve, and E. A. Warburton Falls, Fractures, and Osteoporosis After Stroke: Time to Think About Protection? Stroke, May 1, 2002; 33(5): 1432 - 1436. [Abstract] [Full Text] [PDF]

				Y. Sato, T. Asoh, I. Kondo, and K. Satoh Vitamin D Deficiency and Risk of Hip Fractures Among Disabled Elderly Stroke Patients Stroke, July 1, 2001; 32(7): 1673 - 1677. [Abstract] [Full Text] [PDF]

				Y. Sato, M. Kaji, N. Saruwatari, K. Oizumi, A. Ramnemark, L. Nyberg, Y. Gustafson, R. Lorentzon, and T. Olsson Hemiosteoporosis Following Stroke: Importance of Pathophysiologic Understanding and Histologic Evidence • Response Stroke, September 1, 1999; 30 (9): 1974d - 1981. [Full Text] [PDF]

				Y. Sato, S. Manabe, H. Kuno, and K. Oizumi Amelioration of osteopenia and hypovitaminosis D by 1alpha -hydroxyvitamin D3 in elderly patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, January 1, 1999; 66(1): 64 - 68. [Abstract] [Full Text]

				Y. Sato, H. Kuno, M. Kaji, Y. Ohshima, T. Asoh, and K. Oizumi Increased Bone Resorption During the First Year After Stroke Stroke, July 1, 1998; 29(7): 1373 - 1377. [Abstract] [Full Text] [PDF]

				Y. Sato, Y. Honda, H. Kunoh, and K. Oizumi Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation Stroke, December 1, 1997; 28(12): 2390 - 2394. [Abstract] [Full Text]